A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
复制标题
头孢克洛与甲氧苄啶-磺胺甲恶唑治疗急性中耳炎的随机对照试验。
DOI:
10.1016/s0022-3476(84)80438-2
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
Tutihasi,MA
中科院分区:
文献类型:
--
作者:
Marchant,CD;Shurin,PA;Turcyzk,VA;Feinstein,JC;Johnson,CE;Wasikowski,DE;Knapp,LJ;Tutihasi,MA
We performed a randomized controlled trial of cefaclor administered twice daily compared with trimethoprim-sulfamethoxazole (TMP-SMZ) administered twice daily for the treatment of acute otitis media. Pathogens were eradicated from the middle ear exudate after 3 to 6 days of therapy in 35 of 37 (95%) patients given TMP-SMZ compared with 28 of 40 (70%) given cefaclor (P=0.017).Haemophilus influenzaewas eliminated in 13 of 14 (93%) patients given TMP-SMZ compared with 10 of 18 (56%) given cefaclor (P=0.047). Clinical outcomes failed to distinguish between patients given TMP-SMZ or cefaclor. Symptoms improved despite persistent infection in 11 of 13 (85%) patients; middle-ear effusion persisted after therapy in 38 of 61 (62%) patients despite eradication of pathogens. We conclude that twice daily TMP-SMZ is more efficacious than twice daily cefaclor for the treatment of acute otitis media and that clinical outcomes may fail to detect differences between antibacterial agents in comparative drug trials in acute otitis media.
登录
查看更多内容
影响因子:
4.4
作者:
Patrick H. W. Chu;H. Chan;Y. Ng;B. Brown;A. W. Siu;B. Beale;B. Gilger;F. Wong
通讯作者:
F. Wong
DOI:
10.1113/jphysiol.1983.sp014635
发表时间:
1983
期刊:
The Journal of Physiology
影响因子:
--
作者:
M. Korth
通讯作者:
M. Korth
影响因子:
1.8
作者:
BROWN, KT
通讯作者:
BROWN, KT
影响因子:
5.5
作者:
BROWN, KT;WIESEL, TN
通讯作者:
WIESEL, TN
影响因子:
1.8
作者:
C. K. Adams;W. Dawson
通讯作者:
W. Dawson